CV Sciences, Inc. (CVSI) Financial Statements (2024 and earlier)

Company Profile

Business Address 9530 PADGETT STREET
SAN DIEGO, CA 92126
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6111,3754,0249,10712,6842,013
Cash and cash equivalents6111,3754,0249,10712,6842,013
Receivables7662,0411,1262,1773,3401,508
Inventory, net of allowances, customer advances and progress billings6,5638,6248,8409,9717,1322,823
Inventory6,5638,6248,8409,9717,1322,823
Prepaid expense 3,1902,1462,37210,6112,059813
Other current assets      400
Other undisclosed current assets  501501251379
Total current assets:11,13014,18616,86332,36725,4667,935
Noncurrent Assets
Inventory, Noncurrent     1,4185,667
Operating lease, right-of-use asset275 3,0578,709
Property, plant and equipment5751,7172,8773,6152,8442,083
Intangible assets, net (including goodwill)2511,4856,5186,5546,5896,625
Goodwill   2,7882,7882,7882,788
Intangible assets, net (excluding goodwill)2511,4853,7303,7663,8013,836
Other noncurrent assets5056781,3101,442  
Other undisclosed noncurrent assets     585400
Total noncurrent assets:1,6063,88013,76220,32011,43614,775
TOTAL ASSETS:12,73618,06630,62552,68736,90222,710
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11,97413,53911,48212,4733,9182,610
Accounts payable2,2842,6241,6771,6171,245678
Accrued liabilities9,69010,9159,80510,8562,6731,932
Debt  3102,174723474726
Other undisclosed current liabilities1,340612680   
Total current liabilities:13,31414,46114,33613,1964,3923,336
Noncurrent Liabilities
Long-term debt and lease obligation   3,4679,517 850
Long-term debt, excluding current maturities      850
Liabilities, other than long-term debt199621,6108271,3292,142
Deferred revenue and credits1,067
Deferred revenue   1,453 
Contract with customer, liability1,329
Deferred tax liabilities, net 1,075
Deferred income tax liabilities1162157421
Other liabilities    406  
Operating lease, liability188 3,4679,517
Other undisclosed noncurrent liabilities     1,065 
Total noncurrent liabilities:199625,07710,3442,3942,992
Total liabilities:13,51314,52319,41323,5406,7866,329
Equity
Equity, attributable to parent(777)3,54311,21229,14730,11616,381
Common stock1511101099
Additional paid in capital86,89783,00775,12370,77455,13451,400
Accumulated deficit(87,689)(79,475)(63,921)(41,637)(25,027)(35,028)
Total equity:(777)3,54311,21229,14730,11616,381
TOTAL LIABILITIES AND EQUITY:12,73618,06630,62552,68736,90222,710

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues16,20520,04824,42953,69648,24420,679
Cost of revenue(10,655)(11,432)(13,420)(18,608)(14,366)(6,191)
Gross profit:5,5508,61611,00935,08833,87814,489
Operating expenses(12,397)(27,062)(33,601)(52,328)(23,631)(19,349)
Other undisclosed operating income      
Operating income (loss):(6,847)(18,446)(22,592)(17,240)10,247(4,860)
Nonoperating expense
(Other Nonoperating expense)
    (153)(519)
Interest and debt expense 1272,945  (153)(189)
Income (loss) from continuing operations before equity method investments, income taxes:(6,720)(15,501)(22,592)(17,240)9,941(5,567)
Other undisclosed income (loss) from continuing operations before income taxes(1,541)(140)(9)15153189
Income (loss) from continuing operations before income taxes:(8,261)(15,641)(22,601)(17,225)10,094(5,379)
Income tax expense (benefit)4787317615(93)482
Income (loss) from continuing operations:(8,214)(15,554)(22,284)(16,610)10,001(4,897)
Income (loss) before gain (loss) on sale of properties:(15,554)(22,284)(16,610)10,001(4,897)
Net income (loss):(8,214)(15,554)(22,284)(16,610)10,001(4,897)
Other undisclosed net loss attributable to parent      
Net income (loss) attributable to parent:(8,214)(15,554)(22,284)(16,610)10,001(4,897)
Other undisclosed net loss available to common stockholders, basic (920)     
Net income (loss) available to common stockholders, diluted:(9,134)(15,554)(22,284)(16,610)10,001(4,897)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(8,214)(15,554)(22,284)(16,610)10,001(4,897)
Comprehensive income (loss), net of tax, attributable to parent:(8,214)(15,554)(22,284)(16,610)10,001(4,897)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: